Duracyte is a biotechnology business that develops implantable "living pharmacy" devices.
Duracyte has raised $45.0M in total funding. The most recent round was Grant. The last funding was announced in April 2026.
Duracyte's investors include Advanced Research Projects Agency for Health.
Duracyte is headquartered in Houston, United States.
Duracyte is a biotechnology business that develops implantable "living pharmacy" devices.
Duracyte is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Duracyte — Funding & Investors." VCBacked, April 15, 2026, https://www.vcbacked.co/company/duracyte. Accessed August 14, 2026.
VCBacked. (2026). Duracyte — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/duracyte
{{cite web |title=Duracyte — Funding & Investors |url=https://www.vcbacked.co/company/duracyte |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated